Tricuspid atresia survivor status means living with a single effective ventricle and a staged surgical pathway that typically includes a systemic-to-pulmonary shunt, bidirectional Glenn, and Fontan circulation. As an evergreen profile, this overview explains how circulation changes after birth, how palliation directs blood flow, and how regular follow-up with a specialized adult congenital heart disease (ACHD) team supports long-term health. Modern staged repair enables many people to reach adulthood, yet anatomy, shunt-related issues, and progressive cardiac strain create ongoing considerations for rhythm, heart failure, liver function, and exercise tolerance.
Understanding Tricuspid Atresia Anatomy
In tricuspid atresia, the tricuspid valve is absent or sealed, so blood cannot flow normally from the right atrium to the right ventricle. The right ventricle is typically underdeveloped, and the right side of the heart receives systemic venous return without directly supporting pulmonary blood flow. Survival depends on establishing balanced pulmonary blood flow—either through a natural atrial communication (often a restrictive patent foramen ovale or an ASD) and, in many cases, a controlled systemic-to-pulmonary shunt to prevent excessive lung blood flow or undercirculation.
Key Structural Features
| Anatomic Feature | Verified Detail | Source Type |
|---|---|---|
| Tricuspid valve | Hypoplastic or atretic; no normal opening | Congenital cardiology pathology |
| Right ventricle | Small and underdeveloped (hypoplastic) | Imaging and surgical reports |
| Atrial communication | Often restrictive ASD or PFO | Cardiac catheterization |
| Systemic-to-pulmonary shunt | BT shunt or bidirectional cavopulmonary anastomosis stage 1 | Operative records |
Surgical Palliation Pathway
The standard care sequence is a palliation strategy, not a definitive repair, because the single right ventricle cannot support both systemic and pulmonary circulations independently. The initial systemic-to-pulmonary shunt (often a BT shunt or Sano shunt) stabilizes oxygenation and modulates pulmonary blood flow. Later, the bidirectional Glenn procedure connects the superior vena cava to the pulmonary arteries, reducing ventricular volume work. The final stage, the Fontan circulation, directs inferior and superior venous return directly to the lungs, leaving the single effective ventricle to support systemic output.
Milestone Procedures and Timing
- Systemic-to-pulmonary shunt (stage 1): Often in the first weeks to months of life.
- Bidirectional Glenn: Typically between 4 months and 2 years of age.
- Fontan completion: Generally performed between 1.5 and 3 years, sometimes later if anatomy or physiology require delay.
Some individuals may also undergo pulmonary artery bands or fenestration to manage hemodynamics and protect the organs during early palliation. Decisions are individualized based on anatomy, oxygen saturation, and evidence of ventricular dysfunction.
Long-Term Circulatory Considerations
Fontan circulation produces passive pulmonary blood flow without a right ventricle, so long-term issues reflect the systemic ventricle’s workload and the efficiency of venous return. Potential challenges include chronic hypoxia if saturations are low, ventricular dilation or dysfunction over time, and arrhythmias due to scarring from earlier surgeries. Protein-losing enteropathy, plastic bronchitis, or hepatic congestion can arise when pulmonary blood flow or central venous pressure is persistently elevated.
Central Venous Pressure and Liver Health
Because Fontan circulation relies on passive flow to the lungs, central venous pressure can be elevated. This may lead to hepatic congestion, fibrosis, and, rarely, cirrhosis. Regular assessment of liver enzymes, imaging, and attention to signs of liver dysfunction form part of routine ACHD follow-up. Abnormalities may influence decisions regarding future interventions or transplantation evaluation.
Adult Outcomes, Exercise, and Quality of Life
Many tricuspid atresia survivors reach adulthood and maintain functional independence, but exercise capacity is often reduced compared with the general population. Factors influencing stamina include ventricular function, residual lesions, oxygen saturation, chronotropic incompetence, and arrhythmias. Supervised cardiac rehabilitation and tailored conditioning programs can help optimize strength and tolerance while minimizing symptoms.
- Typical functional status: Variable; many perform light-to-moderate activities comfortably, while high-intensity exertion may provoke fatigue or desaturation.
- Common limitations: Reduced peak oxygen consumption, arrhythmia-induced pauses, ventricular dysfunction.
- Supportive care: ACHD follow-up, physiotherapy, nutrition, and psychosocial services as needed.
Monitoring and Follow-Up Priorities
Lifelong surveillance with an ACHD team helps identify complications early. Core evaluations include echocardiography or cardiac MRI, ECG and Holter or event monitoring for arrhythmias, serial assessment of ventricular function, and hepatic screening. Additional tests may be guided by symptoms, such as exercise testing for functional capacity or CT/MRI for vascular anatomy. Timing of follow-up is individualized, but annual comprehensive reviews are common in stable adults.
Parameters Commonly Tracked in Follow-Up
| Parameter | Verified Detail | Source Type |
|---|---|---|
| Oxygen saturation | Tracked to detect chronic hypoxia | Pulse oximetry, ACHD guidelines |
| Ventricular function | Serial echocardiography or cardiac MRI | Imaging and functional studies |
| Arrhythmias | ECG, Holter or event monitoring | Cardiac monitoring |
| Liver status | Enzymes, imaging for congestion/fibrosis | Blood tests, imaging |
| Exercise tolerance | Exercise testing or functional questionnaires | Clinical exercise testing |
Transition to Adult Care and Psychosocial Aspects
Transitioning from pediatric to ACHD care should begin in adolescence, focusing on understanding the condition, self-management skills, and coordinating insurance and specialty appointments. Psychosocial support is important because living with chronic heart disease can affect education, employment, relationships, and mental health. Peer networks and congenital heart disease–focused resources can provide practical strategies and emotional encouragement for long-term thriving.
When to Consider Transplantation
Heart transplantation may be considered if there is progressive ventricular dysfunction, irreversible liver disease, or unmanageable arrhythmias and heart failure despite optimized medical care. Timing is highly individualized and discussed with an ACHD–transplant team. For candidates and stable survivors without transplant, ongoing medical and surgical optimization remains the primary pathway to sustained well-being.
Tricuspid atresia survivor status reflects decades of evolving therapy, with many adults now pursuing careers, relationships, and active lives. Consistent follow-up, early recognition of complications, and a partnership with an ACHD team help translate anatomical palliation into durable quality of life and long-term survival.